文献速递关节外科

髋关节表面置换术后无症状患者常见不良局部组织反应:前瞻性纵向研究中期报告

Adverse Local Tissue Reactions are Common in Asymptomatic Individuals After Hip Resurfacing Arthroplasty: Interim Report from a Prospective Longitudinal Study.
PubMed 文献 · Clin Orthop Relat Res · 2021-01-01

这项前瞻性纵向研究纳入243髋(206例)关节置换术后患者,比较髋关节表面置换(HRA)与陶瓷对陶瓷(CoC)、金属对聚乙烯(MoP)及陶瓷对聚乙烯(CoP)全髋关节置换(THA)的血液金属离子水平和MRI不良局部组织反应(ALTR)。HRA患者钴和铬离子水平在各时间点均高于CoP,且发生ALTR或金属沉着的风险更高(HR 4.8),但ALTR与患者报告结局无关。

要点

  • HRA患者钴和铬离子水平在各时间点均显著高于CoP患者。
  • HRA患者发生ALTR或金属沉着的风险是CoP患者的4.8倍。
  • MRI可检出无症状HRA患者的ALTR,仅靠问卷或血液离子检测可能漏诊。

核心结论

  • HRA患者MRI检出ALTR或金属沉着的比例高于CoP患者,即使这些患者无症状。
  • MRI可在高功能患者中检出ALTR,强调仅依赖问卷或血液离子检测的年度临床评估可能无法发现软组织并发症。
  • 结果支持将MRI作为该患者人群常规随访方案的一部分。

研究设计与样本

  • 前瞻性纵向研究,单中心,2014年3月至2019年2月,从22,723例初次HRA和THA患者中联系2%(342例),最终纳入243髋(206例)基线分析,25例退出。
  • 纳入术后超过1年的退行性关节病患者,每年进行MRI和血清离子检测并完成髋关节残疾和骨关节炎结局评分(HOOS)问卷,持续四年(基线、第1、2、3年)。
  • MRI由一名不参与患者治疗的放射科医生评估滑膜炎分类、滑膜厚度和体积;使用线性混合效应模型和边缘Cox比例风险模型比较轴承表面,调整年龄、性别、BMI和植入时间,并采用Dunnett-Hsu法校正多重比较。

主要发现

  • 单侧HRA患者钴和铬血清离子水平在各时间点均高于单侧CoP患者(p < 0.001)。
  • HRA患者发生ALTR或金属沉着的风险高于CoP患者(HR 4.8 [95% CI 1.2 to 18.4]; p = 0.02)。
  • MRI上ALTR或金属沉着的纵向变化与患者报告结局无关联。
  • 基线包膜裂开与后续MRI发现ALTR或金属沉着无关联。
  • 单侧HRA伴MRI ALTR或金属沉着的患者第1年钴和铬水平高于无ALTR者(钴:4.7 ± 3.5 ppb vs 1.8 ± 1.0 ppb,平均差4.7 ppb [95% CI 3.3 to 6.0],p < 0.001;铬:4.7 ± 2.6 ppb vs 2.3 ± 0.5 ppb,平均差3.6 ppb [95% CI 2.2 to 5.0],p < 0.001),第3年铬仍较高(3.9 ± 2.4 ppb vs 2.2 ± 1.1 ppb,平均差1.3 ppb [95% CI 0.3 to 2.4],p = 0.01)。

关键数值与推荐

  • HRA患者与CoP患者ALTR或金属沉着风险比较的HR为4.8(95% CI 1.2 to 18.4),p = 0.02。
  • 单侧HRA伴ALTR者第1年钴平均差4.7 ppb(95% CI 3.3 to 6.0),铬平均差3.6 ppb(95% CI 2.2 to 5.0),p < 0.001。
  • 单侧HRA伴ALTR者第3年铬平均差1.3 ppb(95% CI 0.3 to 2.4),p = 0.01。
  • 证据等级为III级,治疗性研究。

临床怎么用

  • 对于HRA术后患者,即使无症状且功能良好,也应考虑将MRI纳入常规随访以检测ALTR。
  • 不应仅依赖患者报告问卷或血液金属离子检测来排除软组织并发症。
  • 血液钴和铬离子水平升高可能提示HRA患者存在ALTR或金属沉着,需进一步MRI评估。

局限性

  • 仅2%的患者被联系参与,可能存在选择偏倚。
  • 研究为单中心设计,结果外推需谨慎。
  • 25例患者退出研究,可能影响纵向数据的完整性。
  • MRI评估由单一放射科医生完成,未报告评估者间可靠性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The evaluation of the natural history prevalence of adverse local tissue reactions (ALTRs) using MRI has focused only on metal-on-metal (MoM) bearing surfaces without comparison to nonMoM bearing surfaces. QUESTIONS/PURPOSES: To determine (1) the longitudinal changes and differences in blood metal ion levels in patients with hip resurfacing arthroplasty (HRA), ceramic-on-ceramic (CoC) THA, and metal-on-polyethylene (MoP) THA compared with those undergoing ceramic-on-polyethylene (CoP) THA; (2) how the longitudinal change of synovial reaction classification in patients with HRA, CoC THA, and MoP THA compares with those undergoing CoP THA, and whether there is an association between the presence of an ALTR or metallosis on MRI with corresponding patient-reported outcomes, or the presence of capsular dehiscence; and (3) differences in blood metal ion levels between patients undergoing HRA with an ALTR or metallosis on MRI and those with HRA without these conditions. METHODS: Between March 2014 and February 2019, 22,723 patients underwent primary HRA and THA at one center. Patients received an HRA based on their desired athletic level after surgery and the presence of normal acetabular and proximal femoral bone morphology without osteopenia or osteoporosis. Two percent (342 of 22,723) of patients were contacted to participate, and 71% (243 of 342 hips in 206 patients) were enrolled for analysis at baseline. The patients underwent arthroplasty for degenerative joint disease, and 25 patients withdrew over the course of the study. We included patients who were more than 1 year postarthroplasty. All participants had an MRI examination and blood serum ion testing and completed a Hip Disability and Osteoarthritis Outcome Score survey annually for four years (baseline, year 1, year 2, year 3). Morphologic and susceptibility-reduced MR images were evaluated by a single radiologist not involved in the care of patients for the presence and classification of synovitis (Gwet AC1: 0.65 to 0.97), synovial thickness, and volume (coefficient of repeatability: 1.8 cm3). Linear mixed-effects models were used to compare the mean synovial thickness, synovial volume, and Hip Disability and Osteoarthritis Outcome Score subscales between bearing surfaces at each timepoint and within each bearing surface over time. Marginal Cox proportional hazards models were used to compare the time to and the risk of developing ALTR only, metallosis only, and ALTR or metallosis between bearing surfaces. All models were adjusted for age, sex, BMI, and length of implantation based on known confounders for hip arthroplasty. Adjustment for multiple comparisons was performed using the Dunnett-Hsu method. RESULTS: Patients with unilateral HRA had higher cobalt and chromium serum ion levels (baseline: 1.8 ± 0.8 ppb, year 1: 2.0 ± 1.5 ppb, year 2: 2.1 ± 1.2 ppb, year 3: 1.6 ± 0.7 ppb) than those with unilateral CoP bearings (baseline: 0.0 ± 0.1 ppb, year 1: 0.1 ± 0.3 ppb, year 2: 0.0 ± 0.2 ppb, year 3: 0.0 ± 0.0 ppb) at all timepoints (p < 0.001 for each time point). More patients who received an HRA developed ALTR or metallosis on MRI than did patients with CoP bearings (hazard ratio 4.8 [95% confidence interval 1.2 to 18.4]; p = 0.02). There was no association between the longitudinal change of synovial reaction to ALTR or metallosis on MRI with patient-reported outcomes. In addition, there was no association between the presence of dehiscence at baseline and the subsequent development of ALTR or metallosis, as seen on MRI. There were elevated cobalt (4.7 ± 3.5 ppb) and chromium (4.7 ± 2.6 ppb) serum levels in patients with unilateral HRA who had an ALTR or metallosis present on MRI at year 1 compared with patients without an ALTR or metallosis on MRI (cobalt: 1.8 ± 1.0 ppb, mean difference 4.7 ppb [95% CI 3.3 to 6.0]; p < 0.001; chromium: 2.3 ± 0.5 ppb, mean difference 3.6 ppb [95% CI 2.2 to 5.0]; p < 0.001) as well as for chromium at year 3 (3.9 ± 2.4 ppb versus 2.2 ± 1.1 ppb, mean difference 1.3 ppb [95% CI 0.3 to 2.4]; p = 0.01). CONCLUSION: We found a higher proportion of ALTR or metallosis on MRI in patients with HRA compared with patients with CoP, even when patient self-assessed symptomatology of those with an ALTR or metallosis on MRI was not different than the absence of these features. MRI detected ALTRs in high-function patients, emphasizing that an annual clinical assessment dependent on survey or blood ion testing alone may not detect soft tissue complications. The results of this study are in line with prior consensus recommendations of using MRI as part of a routine follow-up protocol for this patient population. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Koff MF, Gao MA, Neri JP, et al. Adverse Local Tissue Reactions are Common in Asymptomatic Individuals After Hip Resurfacing Arthroplasty: Interim Report from a Prospective Longitudinal Study. Clin Orthop Relat Res. 2021. PMID: 34232144. doi:10.1097/CORR.0000000000001882

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。